100+ Free ABPS Family Medicine (BCFM) Practice Questions

Pass your ABPS Board of Certification in Family Medicine — Family Medicine Examination (BCFM) exam on the first try — instant access, no signup required.

✓ No registration✓ No credit card✓ No hidden fees✓ Start practicing immediately

Historically high first-time pass rate for residency-trained family physicians (BCFM does not publish exact statistics) Pass Rate

100+ Questions

100% Free

1 / 100

Question 1

Score: 0/0

According to the 2017 ACC/AHA hypertension guideline, what blood pressure threshold defines stage 1 hypertension in adults?

120-129 / <80 mmHg

130-139 / 80-89 mmHg

140-159 / 90-99 mmHg

≥160 / ≥100 mmHg

to track

Same family resources

More ABPS Board Certifications Prep

Continue through related practice pages, study guides, comparisons, and articles from the same exam family.

Practice Pages

ABPS Administrative Medicine Practice100 questions ABPS Anesthesiology (BCA) Practice100 questions ABPS Dermatology (BCD) Practice100 questions ABPS Diagnostic Radiology (BCDR) Practice100 questions ABPS Disaster Medicine Practice100 questions ABPS Emergency Medicine (BCEM) Practice100 questions

2026 Statistics

Key Facts: ABPS Family Medicine (BCFM) Exam

200

Total MCQ Items

ABPS BCFM Family Medicine exam

~4 hr

Total Exam Time

Computer-based testing

~14%

Cardiovascular Weight

Largest single domain on 2026 BCFM content outline

~$1,800

2026 Exam Fee

ABPS/BCFM (verify current schedule)

Age 45

USPSTF CRC Screening Start

USPSTF 2021 grade A recommendation

Age 40

USPSTF Mammography Start

USPSTF 2024 biennial mammography (B grade)

The ABPS Family Medicine (BCFM) Certification Exam is a 200-item, ~4-hour computer-based test for residency-trained MD/DO family physicians. The blueprint covers cardiovascular (~14%), endocrine (~11%), pediatrics (~10%), pulmonary (~9%), women's health (~9%), infectious disease (~9%), GI (~8%), prevention (~8%), geriatrics (~7%), behavioral health (~7%), men's health (~5%), MSK (~5%), dermatology (~4%), and urgent-care procedures (~4%). The 2026 fee is approximately $1,800; eligibility requires completion of an ACGME or AOA-accredited family medicine residency.

Sample ABPS Family Medicine (BCFM) Practice Questions

Try these sample questions to test your ABPS Family Medicine (BCFM) exam readiness. Each question includes a detailed explanation. Start the interactive quiz above for the full 100+ question experience with AI tutoring.

1According to the 2017 ACC/AHA hypertension guideline, what blood pressure threshold defines stage 1 hypertension in adults?

A.120-129 / <80 mmHg

B.130-139 / 80-89 mmHg

C.140-159 / 90-99 mmHg

D.≥160 / ≥100 mmHg

Explanation: The 2017 ACC/AHA guideline defines stage 1 HTN as systolic 130-139 OR diastolic 80-89 mmHg, lowered from the previous JNC threshold. Stage 2 is ≥140 OR ≥90 mmHg. Elevated BP is 120-129 / <80 mmHg. Pharmacotherapy is recommended for stage 1 HTN if 10-year ASCVD risk ≥10% or established CVD/CKD/diabetes, otherwise lifestyle first.

2A 58-year-old man with a 10-year ASCVD risk of 14% and no contraindications is starting primary prevention statin therapy. According to the 2018 ACC/AHA cholesterol guideline, which intensity statin is recommended?

A.Low-intensity statin (e.g., simvastatin 10 mg)

B.Moderate-intensity statin (e.g., atorvastatin 10-20 mg)

C.High-intensity statin only

D.No statin until LDL ≥190 mg/dL

Explanation: For primary prevention with intermediate risk (7.5-19.9% 10-year ASCVD), a moderate-intensity statin is recommended (LDL reduction 30-49%). High-intensity statins (LDL reduction ≥50%) are reserved for clinical ASCVD, LDL ≥190, diabetes age 40-75 with multiple risk factors, or 10-year ASCVD risk ≥20%. Atorvastatin 10-20 mg or rosuvastatin 5-10 mg are common moderate-intensity choices.

3A 70-year-old woman with HFrEF (EF 30%) is on lisinopril, metoprolol succinate, and furosemide. Which medication addition provides the largest mortality benefit per current GDMT?

A.Add digoxin

B.Switch lisinopril to sacubitril-valsartan (ARNI) and add spironolactone and an SGLT2 inhibitor

C.Add amlodipine for afterload reduction

D.Add ivabradine

Explanation: Quadruple therapy GDMT for HFrEF — ARNI (replacing ACEi/ARB), beta-blocker, MRA (spironolactone or eplerenone), and SGLT2 inhibitor (dapagliflozin or empagliflozin) — provides the largest survival benefit. SGLT2 inhibitors reduce CV death/HF hospitalization regardless of diabetes status. Allow ≥36 hr washout between ACEi and ARNI to avoid angioedema risk.

4A 72-year-old man with new atrial fibrillation has a CHA2DS2-VASc score of 3 (age, HTN, diabetes). Renal function is normal. Which is the preferred anticoagulation strategy?

A.Aspirin 81 mg daily

B.Warfarin with target INR 2-3

C.A direct oral anticoagulant (DOAC) such as apixaban or rivaroxaban

D.No anticoagulation needed

Explanation: DOACs are preferred over warfarin for non-valvular AFib with CHA2DS2-VASc ≥2 in men or ≥3 in women. They have similar efficacy to warfarin with lower rates of intracranial hemorrhage and no INR monitoring. Warfarin remains preferred for valvular AFib (mechanical valves, moderate-severe mitral stenosis) and severe renal impairment. Aspirin is not recommended for stroke prevention in AFib.

5A 60-year-old presents with new-onset chest pain at rest, troponin elevated, and ST depression on ECG. What is the most likely diagnosis?

A.STEMI

B.NSTEMI

C.Stable angina

D.Pericarditis

Explanation: NSTEMI is defined by elevated troponin without ST elevation — typically with ST depression or T-wave inversion. Initial management: dual antiplatelet (aspirin + P2Y12 inhibitor), anticoagulation (heparin), statin, nitrates as needed, and risk stratification with TIMI/GRACE scores to guide timing of invasive strategy. STEMI requires immediate reperfusion (PCI within 90 minutes door-to-balloon).

6Per JNC-8 / ACC/AHA, which is an appropriate first-line antihypertensive for a 55-year-old African American adult without diabetes or CKD?

A.Lisinopril

B.Losartan

C.Thiazide diuretic or calcium channel blocker (e.g., chlorthalidone or amlodipine)

D.Atenolol

Explanation: JNC-8 recommends thiazide diuretics or CCBs as first-line in non-Black or Black adults without compelling indications, with thiazides/CCBs preferred over ACEi/ARBs in Black patients due to greater BP-lowering response and reduced stroke risk in landmark trials. ACEi/ARBs are first-line when CKD with proteinuria or diabetes is present.

7A 65-year-old man has fasting glucose 168 mg/dL, A1C 8.4%, BMI 32, and known CAD. Per the 2025 ADA Standards of Care, which initial pharmacotherapy is preferred?

A.Metformin alone

B.Sulfonylurea alone

C.Metformin plus a GLP-1 RA or SGLT2 inhibitor with proven cardiovascular benefit

D.Basal insulin alone

Explanation: The 2025 ADA Standards recommend metformin plus an agent with proven CV benefit (GLP-1 RA or SGLT2 inhibitor) for patients with established ASCVD, regardless of A1C or metformin use. SGLT2i is preferred for HF or CKD; GLP-1 RA is preferred when ASCVD predominates or significant weight loss is desired. Empagliflozin, dapagliflozin, semaglutide, and liraglutide have proven CV outcomes.

8A 45-year-old woman has TSH 12.5 mIU/L (high) and free T4 0.6 ng/dL (low). What is the most appropriate initial therapy?

A.Methimazole 10 mg daily

B.Levothyroxine, with dose based on weight (~1.6 mcg/kg/day)

C.Radioactive iodine ablation

D.Beta-blocker only

Explanation: This is overt primary hypothyroidism — treat with levothyroxine. Full replacement dose is approximately 1.6 mcg/kg/day in healthy adults; start lower (25-50 mcg) in elderly or those with CAD. Recheck TSH in 6-8 weeks and titrate. Methimazole and RAI treat hyperthyroidism, not hypothyroidism.

9A 58-year-old postmenopausal woman has a DXA T-score of -2.6 at the femoral neck. She has no prior fractures. What is the most appropriate next step?

A.Observation only

B.Calcium and vitamin D supplementation alone

C.Initiate oral bisphosphonate (e.g., alendronate) plus calcium and vitamin D

D.Initiate teriparatide as first-line

Explanation: T-score ≤ -2.5 meets osteoporosis criteria and is an indication for pharmacotherapy. First-line is an oral bisphosphonate (alendronate or risedronate) plus calcium 1200 mg/day and vitamin D 800-1000 IU/day. Teriparatide and romosozumab are reserved for very high fracture risk or bisphosphonate failure. Counsel on bisphosphonate dosing (empty stomach, upright 30 min).

10A 52-year-old woman with new diabetes has eGFR 55 and UACR 350 mg/g. Which medication class is most strongly indicated to slow CKD progression beyond standard glycemic control?

A.Sulfonylurea

B.DPP-4 inhibitor

C.SGLT2 inhibitor (e.g., dapagliflozin or empagliflozin)

D.Pioglitazone

Explanation: SGLT2 inhibitors slow CKD progression and reduce albuminuria in diabetic and non-diabetic CKD. The 2025 ADA Standards recommend SGLT2i for T2DM with eGFR ≥20 mL/min/1.73m² and UACR ≥200 mg/g (and with eGFR ≥20 regardless of UACR per recent expansions). ACEi/ARB titration to maximally tolerated dose is also key. Finerenone (non-steroidal MRA) provides additional renoprotection in DKD.

About the ABPS Family Medicine (BCFM) Exam

The ABPS Family Medicine Certification Examination, administered by the Board of Certification in Family Medicine (BCFM) under the American Board of Physician Specialties (ABPS), validates broad-spectrum primary care competencies for MD/DO family physicians. Content spans cardiovascular disease (HTN per ACC/AHA, lipids, CAD, HF GDMT, AFib with CHA2DS2-VASc), endocrinology (T2DM with 2025 ADA Standards, thyroid, adrenal, osteoporosis), pulmonary (asthma GINA 2025 with ICS-formoterol MART, COPD GOLD 2025 ABE), gastroenterology (GERD, H. pylori, viral hepatitis, CRC screening from age 45), infectious disease (CDC 2026 STI guidelines, IDSA pneumonia, UTI), women's health (USPSTF cervical HPV q5y, biennial mammography from age 40, contraception), men's health (BPH, ED, prostate screening), pediatrics and adolescent care (Bright Futures, ACIP 2025-2026 schedule), geriatrics (Beers 2023, frailty, polypharmacy, STEADI falls), behavioral health (PHQ-9, GAD-7, SSRI selection, MAT for OUD), dermatology, musculoskeletal, prevention/screening (USPSTF 2026), and urgent care procedures. Eligibility requires MD/DO with unrestricted license and completion of an ACGME or AOA-accredited family medicine residency.

Questions

200 scored questions

Time Limit

~4 hours CBT

Passing Score

Criterion-referenced scaled score set by BCFM (modified Angoff standard)

Exam Fee

~$1,800 examination fee (ABPS/BCFM 2026 — verify current schedule) (American Board of Physician Specialties (ABPS) — Board of Certification in Family Medicine (BCFM))

ABPS Family Medicine (BCFM) Exam Content Outline

~12%

Cardiovascular Disease

Hypertension (ACC/AHA 2017 thresholds ≥130/80, JNC-8 first-line agents — thiazide, ACEi/ARB, CCB, resistant HTN, secondary causes), dyslipidemia (2018 ACC/AHA cholesterol guideline, statin intensity by 10-year ASCVD risk, PCSK9 inhibitors, lipoprotein(a)), stable CAD and ACS (NSTEMI/STEMI initial management, dual antiplatelet therapy duration), heart failure (HFrEF GDMT — ARNI, beta-blocker, MRA, SGLT2 inhibitor quadruple therapy), atrial fibrillation (CHA2DS2-VASc, DOAC vs warfarin, rate vs rhythm), valvular disease, PAD, syncope workup.

~10%

Endocrinology & Metabolism

Type 2 diabetes (2025 ADA Standards of Care — metformin first-line, GLP-1 RA and SGLT2i for ASCVD/HF/CKD, individualized A1C targets, CGM expansion), Type 1 diabetes, DKA/HHS, thyroid disease (hypo/hyperthyroidism, thyroid nodule workup, ATA pregnancy guidelines), adrenal disorders (Addison, Cushing, pheochromocytoma), osteoporosis (DXA, FRAX, bisphosphonates, denosumab), obesity (semaglutide, tirzepatide), PCOS (Rotterdam criteria), hyperprolactinemia.

~9%

Pediatrics & Adolescent Care

AAP Bright Futures well-child schedule, ACIP 2025-2026 childhood/adolescent immunization schedule, developmental milestones, growth charts and failure to thrive, common pediatric infections (acute otitis media, bronchiolitis, croup, hand-foot-mouth), febrile seizures, ADHD, autism screening (M-CHAT-R), adolescent confidentiality and HEEADSSS interview, eating disorders, contraception in adolescents, sports preparticipation evaluation, lead screening, neonatal jaundice.

~8%

Pulmonary & Allergy

Asthma (GINA 2025 stepwise therapy — ICS-formoterol MART preferred for steps 3-5, biologics for severe eosinophilic disease), COPD (GOLD 2025 ABE assessment, LAMA/LABA, triple therapy ICS/LABA/LAMA when indicated, pulmonary rehab), community-acquired pneumonia (IDSA/ATS 2019 guidelines), pulmonary embolism (Wells score, PERC rule, D-dimer, DOAC treatment), obstructive sleep apnea, bronchitis, allergic rhinitis, anaphylaxis (epinephrine first-line).

~8%

Women's Health & Reproductive Care

Cervical cancer screening (USPSTF — primary HPV testing every 5 years age 30-65), breast cancer screening (USPSTF 2024 — biennial mammography starting age 40), contraception (CDC US Medical Eligibility Criteria, LARC counseling), preconception care, normal pregnancy and prenatal care, gestational diabetes (1-step vs 2-step), hypertensive disorders of pregnancy, postpartum care and depression (Edinburgh), perimenopause and menopausal hormone therapy, abnormal uterine bleeding (PALM-COEIN), vaginitis.

~8%

Infectious Disease & Antibiotic Stewardship

CDC 2026 STI Treatment Guidelines (gonorrhea single-dose IM ceftriaxone 500 mg, chlamydia doxycycline 100 mg BID × 7 days first-line, syphilis benzathine PCN G), UTI (uncomplicated cystitis — nitrofurantoin/TMP-SMX/fosfomycin), pyelonephritis, cellulitis and skin/soft-tissue infection (MRSA), pharyngitis (Centor/McIsaac, GAS), otitis media, sinusitis, influenza and COVID-19, HIV (PrEP, ART), TB screening (IGRA preferred), Lyme disease, ACIP 2025-2026 immunizations.

~7%

Gastroenterology

GERD (PPI step-down, alarm features prompting endoscopy), peptic ulcer disease, H. pylori (test-and-treat, quadruple therapy if macrolide resistance >15%), IBS Rome IV criteria, IBD (Crohn vs UC), celiac disease (tTG-IgA), viral hepatitis (HCV DAA cure, HBV management), NAFLD/MASLD, diverticulitis, colorectal cancer screening (USPSTF 2021 — start age 45 for average risk), constipation, hemorrhoids.

~7%

Prevention, Screening & Health Maintenance

USPSTF 2026 A/B grade recommendations (cancer screening, lipid screening, AAA one-time for men 65-75 who ever smoked, statin primary prevention age 40-75 with ≥1 risk factor and ≥10% ASCVD), ACIP 2025-2026 adult immunization schedule (RSV ≥75 universally, shingles Shingrix ≥50, pneumococcal PCV20/PCV21, COVID-19, influenza, Tdap), tobacco/alcohol/substance counseling (5 As, USAUDIT), BMI and obesity counseling, motor vehicle safety, pre-travel medicine, occupational health.

~6%

Geriatrics

Beers Criteria 2023 (anticholinergics, benzodiazepines, sulfonylureas, NSAIDs, PPIs in elderly), polypharmacy and deprescribing, frailty assessment, falls assessment (CDC STEADI), dementia (Alzheimer, vascular, Lewy body, frontotemporal — distinguishing features), delirium (CAM, hyperactive vs hypoactive), urinary incontinence (urge, stress, overflow), geriatric depression scale (GDS), advance care planning, Medicare Annual Wellness Visit, code status and POLST.

~6%

Behavioral Health & Psychiatry

USPSTF anxiety screening (adults all ages — 2023; adolescents 8-18) and depression screening (PHQ-9, GAD-7), SSRI/SNRI selection and monitoring (FDA black box for adolescents), bipolar disorder, panic disorder, PTSD (PCL-5), ADHD in adults, substance use disorders (AUDIT-C, MAT — buprenorphine, naltrexone, methadone), tobacco cessation (5 As, varenicline highest efficacy), suicide risk assessment, eating disorders, somatic symptom disorder, insomnia (CBT-I first-line).

~5%

Men's Health

Benign prostatic hyperplasia (alpha-blockers — tamsulosin, 5-alpha reductase inhibitors — finasteride for prostate >40g), prostate cancer screening (USPSTF — shared decision-making age 55-69, against routine ≥70), erectile dysfunction (PDE5 inhibitors, cardiovascular workup as ED is CV disease marker), testicular cancer (painless mass, ultrasound), hypogonadism and testosterone therapy, varicocele, epididymitis (under 35 — STI coverage).

~6%

Musculoskeletal & Sports Medicine

Low back pain (red flags — cauda equina, malignancy; conservative first-line — NSAIDs, activity), osteoarthritis, rheumatoid arthritis (DMARDs early), gout (urate-lowering therapy with allopurinol, target serum urate <6 mg/dL), fibromyalgia (duloxetine, pregabalin), common orthopedic injuries (rotator cuff, ACL/meniscus, ankle sprain — Ottawa rules), carpal tunnel, plantar fasciitis, sports preparticipation, concussion management (gradual return to play/learn).

~4%

Dermatology

Acne (topical retinoids first-line, benzoyl peroxide, oral antibiotics, isotretinoin for severe nodulocystic), psoriasis, atopic dermatitis (emollients, topical steroids), contact dermatitis, rosacea (metronidazole, ivermectin), melanoma ABCDE and skin cancer screening (USPSTF — insufficient evidence for routine total-body), basal cell and squamous cell carcinoma, actinic keratosis, urticaria (H1 blockers), tinea infections, scabies (permethrin), herpes zoster (Shingrix), nail disorders, alopecia.

~4%

Urgent Care & Office Procedures

Laceration repair and wound management (suture material/timing), abscess incision and drainage, joint and trigger-point injections, skin biopsy (shave/punch/excisional), cryotherapy with liquid nitrogen, IUD insertion and removal, splinting and casting basics, foreign body removal, epistaxis management (Kiesselbach plexus), ear lavage, common acute presentations (chest pain triage, syncope workup, headache red flags — thunderclap, focal deficit, age >50).

How to Pass the ABPS Family Medicine (BCFM) Exam

What You Need to Know

Passing score: Criterion-referenced scaled score set by BCFM (modified Angoff standard)
Exam length: 200 questions
Time limit: ~4 hours CBT
Exam fee: ~$1,800 examination fee (ABPS/BCFM 2026 — verify current schedule)

Keys to Passing

Complete 500+ practice questions
Score 80%+ consistently before scheduling
Focus on highest-weighted sections
Use our AI tutor for tough concepts

ABPS Family Medicine (BCFM) Study Tips from Top Performers

1Memorize the 2025 ADA Standards of Care updates — GLP-1 RAs and SGLT2 inhibitors are recommended independent of A1C and metformin in patients with established ASCVD, heart failure, or CKD. SGLT2i are preferred in HF with reduced or preserved EF and in CKD with eGFR ≥20. GLP-1 RAs are preferred when ASCVD predominates or weight loss is needed. Individualize A1C targets (often <7% for most adults, less stringent in elderly/comorbid).

2GINA 2025 asthma stepwise therapy: ICS-formoterol MART (maintenance and reliever therapy) is preferred at steps 3-5 across ages 12+. SABA-only is no longer recommended at any step due to mortality risk — every patient gets ICS-containing therapy. For severe eosinophilic asthma, biologics (omalizumab, mepolizumab, benralizumab, dupilumab, tezepelumab) are added at step 5. Know the difference between MART and conventional dosing.

3GOLD 2025 COPD: assessment is now ABE (not ABCD — group C was eliminated in 2023). Group A = low symptoms, low exacerbation; Group B = high symptoms, low exacerbation (LABA + LAMA); Group E = ≥2 exacerbations or 1 hospitalization regardless of symptoms (LABA + LAMA, add ICS only if blood eosinophils ≥300 or persistent exacerbations on dual bronchodilator). Triple therapy (ICS/LABA/LAMA) is reserved for severe disease.

4USPSTF 2026 high-yield grades: breast cancer screening biennial mammography starting age 40 (B grade, finalized 2024), colorectal cancer screening starting age 45 through 75 (A grade), lung cancer LDCT screening 50-80 with 20 pack-year history within 15 years of quitting (B grade), AAA one-time ultrasound for men 65-75 who ever smoked (B grade), statin primary prevention 40-75 with ≥1 CVD risk factor and ≥10% 10-year ASCVD risk (B grade), anxiety screening for all adults (B grade, 2023).

5ACIP 2025-2026 adult immunization pearls: RSV vaccine universally recommended for ≥75 (and 50-74 with risk factors, single dose), pneumococcal — PCV20 single dose OR PCV15 followed by PPSV23 OR new PCV21 (Capvaxive) for adults ≥50 (lowered from 65 in 2024), shingles Shingrix 2-dose for ≥50 immunocompetent and ≥19 immunocompromised, COVID-19 updated annually, influenza annually with high-dose preferred for ≥65.

6CDC 2026 STI Treatment Guidelines updates: gonorrhea — single 500 mg IM ceftriaxone (1 g if ≥150 kg), no longer routinely covering chlamydia in same regimen unless not excluded. Chlamydia — doxycycline 100 mg BID × 7 days is first-line (azithromycin single 1 g dose is alternative; doxycycline more effective for rectal infection). Syphilis — benzathine PCN G dosing depends on stage (single dose for early, 3 weekly doses for late latent). Doxy-PEP (200 mg within 72 hours) for MSM/transgender women at high risk.

Frequently Asked Questions

What is the ABPS Family Medicine (BCFM) Certification Examination?

The ABPS Family Medicine Certification Examination is administered by the Board of Certification in Family Medicine (BCFM) under the American Board of Physician Specialties (ABPS). It validates the broad-spectrum primary care competencies expected of family physicians, covering cardiovascular disease, endocrinology, pulmonary, GI, infectious disease, women's and men's health, pediatrics, geriatrics, behavioral health, dermatology, MSK, prevention/screening, and urgent care procedures.

How does ABPS BCFM differ from ABFM (American Board of Family Medicine)?

ABFM is the ABMS (American Board of Medical Specialties) member board and is the most widely recognized family medicine credential in the US. ABPS BCFM is a separate non-ABMS pathway recognized by many hospitals, payers, and state medical boards. Eligibility, content, and standard-setting differ but both attest to family medicine competency. Some physicians hold both.

Who is eligible to take the BCFM exam?

Candidates must hold an MD, DO, or equivalent doctoral medical degree with a valid unrestricted medical license and have completed an ACGME or AOA-accredited family medicine residency program. Letters of reference attesting to current full and unrestricted clinical practice are required, along with adherence to the ABPS Code of Ethics.

What is the format of the exam?

The BCFM Family Medicine exam is a computer-based test comprising approximately 200 single-best-answer multiple-choice questions over approximately 4 hours. Items are blueprinted to the BCFM content outline: Cardiovascular (~14%), Endocrine (~11%), Pediatrics (~10%), Pulmonary (~9%), Women's Health (~9%), Infectious Disease (~9%), GI (~8%), Prevention/Screening (~8%), Geriatrics (~7%), Behavioral Health (~7%), Men's Health (~5%), MSK (~5%), Dermatology (~4%), Urgent Care/Procedures (~4%). Testing is at secure CBT centers.

How much does the 2026 exam cost?

The 2026 BCFM Family Medicine examination fee is approximately $1,800 — always verify the current schedule on the ABPS website. Candidates should also budget for board review course materials (~$500-$2,000 optional) and ongoing Continuous Certification (CC) fees after passing. Cancellation and refund policies follow the BCFM schedule with decreasing refunds as the exam date approaches.

How is the exam scored?

BCFM uses criterion-referenced scaled scoring with a passing standard set by subject-matter experts using the modified Angoff method. A candidate's pass/fail result depends on performance relative to the fixed cut-score, not on other candidates. Score reports typically include domain-level feedback so candidates know their strongest and weakest content areas.

What are the highest-yield 2026 topics?

Highest-yield 2026 topics include the 2025 ADA Standards of Care (GLP-1 RA and SGLT2 inhibitors for ASCVD/HF/CKD regardless of A1C, individualized A1C targets), GINA 2025 asthma stepwise therapy with ICS-formoterol MART for steps 3-5, GOLD 2025 COPD ABE assessment, USPSTF 2024 biennial mammography starting age 40, USPSTF colorectal cancer screening starting age 45, ACIP 2025-2026 immunization schedule (RSV for ≥75, PCV20/PCV21, shingles), CDC 2026 STI Treatment Guidelines (ceftriaxone 500 mg single-dose for gonorrhea, doxycycline first-line for chlamydia), Beers Criteria 2023 high-risk medications, USPSTF anxiety screening across adults and adolescents, and HFrEF quadruple GDMT (ARNI, BB, MRA, SGLT2i).

How should I study for this exam?

Use a structured 6-12 month plan layered on residency or active practice. Map to the BCFM content outline: begin with cardiology, endocrine, and pulmonary; then GI, infectious disease, and women's/men's health; then pediatrics, geriatrics, and behavioral health; close with derm, MSK, prevention, and procedures. Use AAFP board review materials, MKSAP for relevant chapters, USPSTF and CDC primary-source guidelines, ACC/AHA, ADA, GINA, GOLD, and high-volume MCQ practice. Complete 2-3 timed full-length mock exams in the final 2 months.